GenFlow Bio

GenFlow Bio

Organization

Heard in 6 episodes across 4 shows since Aug 2026

A biotechnology company developing gene therapies and longevity-related treatments, including programs targeting sarcopenia, glaucoma, and MASH.

Episodes

6
across 4 shows

First heard

Aug 2026

Expert statements

2
2 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20262
Oct 20263

What experts have said about GenFlow Bio

2 statements · 2 positive

  1. Eric LeirePositiveSep 13, 2026· The Sunday Roast

    A granted patent would materially increase GenFlow’s animal-health deal value.

    “if we have a patent granted, issued, that will have a major impact on the value of the deal.”

    Listen at 33:23

    Open the episode · S12 Ep2: The Sunday Roast featuring Genflow Biosciences, Energy Pathways and Buccaneer Energy #GENF #EPP #BUCE #INC #KEN #FMET #GMET #SVML #UOG #TGR #TAR #XTR #AFP #SRVL
  2. Eric LeirePositiveSep 13, 2026· The Sunday Roast

    GenFlow’s animal-health deal valuation will exceed its market capitalization.

    “the valuation of the deal will always be superior to our market cap.”

    Listen at 35:16

    Open the episode · S12 Ep2: The Sunday Roast featuring Genflow Biosciences, Energy Pathways and Buccaneer Energy #GENF #EPP #BUCE #INC #KEN #FMET #GMET #SVML #UOG #TGR #TAR #XTR #AFP #SRVL
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

6 episodes featuring GenFlow Bio, newest first

GenFlow Bio · PodLume